Value Communication

Global Value Dossier

Scope of service:

• Development of a comprehensive Global Value Dossier (GVD): The preparation of a comprehensive, evidence-based document is to be undertaken, the purpose of which is to consolidate key information about the medicinal product or medical device under analysis.

• Presentation of the value of the assessed product: The presentation will comprise of evidence that confirms the value of the assessed medical product, including clinical and economic data, as well as its impact on patients' quality of life.

• HTA compliance: The GVD will be designed in accordance with the templates and requirements of the HTA Agency in the target regions, with a view to ensuring the facilitation of reimbursement processes.

• Support for communication with stakeholders: The development of communication materials, including slide decks and training courses, will be undertaken to ensure the effective conveyance of the assessed product's value to diverse audiences.

Benefits:

• Consistent and compelling value story: A comprehensive document will be provided, which will describe the value of the product in detail. This document will be adaptable to local teams, who will use it to support launch activities such as payer negotiations and reimbursement submissions.

• Effective support for local teams: GVD will function as a central source of information, assisting local teams in their preparations for negotiations with payers and the submission of reimbursement applications.

• Compliance with international standards: The development of our GVDs conforms to international standards and best practices, thereby ensuring their universal applicability and the effective utilisation of the prepared material across diverse regions.

• Faster market access: When a GVD has been meticulously prepared, product evaluation and approval processes by regulatory authorities and payers can be facilitated, resulting in expedited product launches.

Payer Value Proposition

Scope of service:

• Strategic document: The document will comprise a set of data on the clinical and economic value of the product, as well as its value in a broader systemic context. The scope of data and the manner of its presentation will be determined by taking into account the Client's expectations and in response to the indicated reimbursement objectives.

• Clinical value: The data to be presented will concern the health benefits of the evaluated product, including efficacy and safety data, an assessment of unmet medical needs, and other aspects related to the use of the evaluated product that have a real impact on the health outcomes achieved by patients.

• Economic value: The economic impact of introducing a new product will be assessed using cost-effectiveness models, and the impact on the public payer's budget and the entire healthcare system will be analysed.

Benefits:

• Competitive value: The data presented will enable the evaluated product to be distinguished from existing alternative treatment options by highlighting its unique features and the health benefits it offers to patients.

• Effective reimbursement tool: A well-prepared analysis is crucial to increasing the chances of success in gaining market access or maintaining a favourable reimbursement decision.

Key Value Message

Scope of service:

• Communication document: The development of a document containing a summary of key messages about the most important benefits and advantages of the assessed product will be completed in a clear and comprehensible way for various target groups, including clinical experts, payers, healthcare providers, and patients.

• Accuracy and conciseness of messages: Messages will be presented in a manner that is clear, legible and concise.

• Indication of the competitiveness of the evaluated product: The purpose of this document is to highlight the features of the evaluated product that best characterise its benefits and make it unique compared to available alternatives.

Benefits:

• Perception of the assessed product: The effective communication of key values and the establishment of a communication strategy with stakeholders based on these values genuinely support the best possible understanding of messages by all parties involved in the process, in a manner desired by the applicant.

• Obtaining real support for product-related initiatives: Conscious involvement of various groups increases the chances of obtaining their support for planned marketing and reimbursement activities.

Objection handler

Scope of service:

• Comprehensive objection handler: A detailed analysis will be conducted to identify potential obstacles in the refund application process, with the aim of developing an effective risk management strategy. The analysis presented will be based on the most recent research and market data, enabling precise identification of issues.

• Personalised responses: Responses are adapted to align with the specific needs and expectations of stakeholder groups. The responses provided are founded upon scientific evidence and knowledge, thereby enhancing their credibility and effectiveness.

• Proactive management: Proactive management strategies are developed to enable the early identification and elimination of potential problems. This approach serves to mitigate the potential for delays and complications that may arise during the reimbursement process.

• Communication support: The provision of assistance in the communication with decision-makers and stakeholders is facilitated, with the objective of ensuring the effective conveyance of key information and arguments. The services offered by our organisation encompass the preparation of presentation materials, reports, and other communication tools.

Benefits:

• Process predictability: The comprehensive understanding of the reimbursement system and the diverse needs of all stakeholders facilitates the precise anticipation of potential risks and their effective mitigation.

• Easier access to the market: Active management and providing individual attention to clients' needs ensures more efficient access to the market.

• Strong partnership: We prioritise cooperative efforts to identify solutions and formulate rational, compelling responses to taxpayers' concerns, thereby fostering a robust partnership.

Scientific Conferences and Publications

Scope of service:

• Professional summaries and abstracts: The preparation of concise and clear summaries of the key assumptions and results of HTA reports or other studies prepared for clients may be undertaken.

• Compelling posters: The posters prepared by our Team present the results of analyses in an accessible and attractive way. The provision of material for presentation at conferences, advisory board meetings, and for publication on our clients' websites as informational material is also facilitated.

• Scientific publications: The publication of reports and other studies prepared for clients in reputable scientific journals may be supported. The company's extensive experience and knowledge of editorial requirements enables it to carry out the entire process effectively.

Benefits:

• Cooperation and networking: The establishment of contacts with other professionals and experts in the industry is facilitated, and through cooperation in similar areas, the initiation of broader discussions on the issues discussed in our publications is encouraged.

• Expanding knowledge: The sharing of expertise has the potential to facilitate the identification of innovative solutions and the exploration of new research areas.

• Global reach: In consequence of the increased availability of publications on a global scale, authors are able to promote their ideas with greater efficacy.